SELDI ProteinChip® array in oncoproteomic research

Technology in Cancer Research and Treatment

Volumn 1, Issue 4, 2002, Pages 273-279

  Yip, Tai Tung ^a   Lomas, Lee ^a  

^a CIPHERGEN BIOSYSTEMS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

CANCER DIAGNOSIS; CANCER GROWTH; CANCER RESEARCH; CANCER STAGING; DEVICE; HEALTH CARE INDUSTRY; PROTEOMICS; SHORT SURVEY; DISEASE COURSE; HUMAN; METABOLISM; NEOPLASM; PROGNOSIS; PROTEIN MICROARRAY; REVIEW;

DISEASE PROGRESSION; HUMANS; NEOPLASMS; PROGNOSIS; PROTEIN ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0038561093     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460200100408     Document Type: Short Survey

References (18)

1. Cancer Facts and Figures, American Cancer Society, Inc., Surveillance Research (2002).
2. van't Veer, L. J., H. Dai, M. J. van de Vijver, Y. He, A. A. M. Hart, M. M., H. L. Peterse, K. van der Kooy, M. J. Marton, A. T. Witteveen, G. J. Schreiber, R. M. Kerkhoven, C. Roberts, P. S. Linsley, R. Bernards and S. H. Friend. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536 (2002).
3. Pandey, A. and M., Mann. Proteomics to study genes and genomes. Nature 405, 837-846 (2000).
4. Jenkins, R. E. and S. R. Pennington. Arrays for protein expression profiling: Towards a viable alternative to two-dimensional gel electrophoresis? Proteomics 1, 13-29 (2001).
5. Weinberger, S., T. S. Morris and M. Pawlak. Recent trends in protein biochip technology. Pharmacogenomics 1, 395-416 (2000).
6. Paweletz, C. P., F. Li, B. J. Trock, E. F. Petricoin, L. A. Liotta. Diagnosis of breast cancer from nipple aspirate fluids based on multiparametric proteomic analysis. AACR 2002, SF, CA (2002).
7. Cazares, L. H., B. L. Adam, M. D. Ward, S. Nasim, P. F. Schellhammer, G. L. Wright Jr. Discovery of Distinct Protein Patterns for Normal, Benign, Pre-Neoplastic and Malignant Prostate Epithelial Cells by SELDI Mass Spectrometry. AACR 2002, SF, CA (2002).
8. Wu, W., W. Hu, W. K. Hong, L. Mao. Rapid screening and identifi- cation of serum tumor-associated markers in patients with resectable non-small cell lung cancer. AACR 2002, SF, CA (2002).
9. Wright, G. L., L. H. Cazares, S. M. Leung, S. Nasim, B. Adam, T. T. Yip, P. F. Schellhammer, L. Gong and A. Vlahou. ProteinChip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: A novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer and Prostatic Diseases 2, 264-276 (1999).
10. Paweletz, C. P., J. W. Gillespie, D. K. Ornstein, N. L. Simone, M. R. Brown, D. A. Cole, Q. H. Wang, J. Huang, N. Hu, T. T. Yip, W. E. Rich, E. C. Kohn, W. M. Linehan, T. Weber, P. Taylor, M. R. Emmert-Buck, L. A. Liotta, and E. F. Petricoin. Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip. Drug Development Research 49, 34-42 (2000).
11. Wulfkuhle, J. D., K. C. McLean, C. P. Paweletz, D. C. Sgroi, B. J. Trock, P. S. Steeg, E. F. Petricoin. New approaches to proteomic analysis of breast cancer. Proteomics 1, 1205-15 (2001).
12. Wellmann, A., V. Wollscheid, H. Lu, M. ZI, P. Albers, K. Schutze, V. Rohde, P. Behrens, S. Dreschers, Y. Ko, N. Wernert. Analysis of microdissected prostate tissue with ProteinChip® arrays - a way to new insights into carcinogenesis and to diagnostic tools. Int. J. Mol. Med. 9, 341-7 (2002).
13. Craven, R. A., R. E. Banks. Laser capture microdissection and proteomics, possibilities and limitations. Proteomics 1, 1200-1204 (2001).
14. Adam, B. L., A. Vlahou, O. J. Semmes, G. L. Wright Jr. Proteomic approaches to biomarker discovery in prostate and bladder cancers. Proteomics 1, 1264-1270 (2001).
15. Von Eggeling, F., K. Junker, W. Fiedler, V. Wollscheid, M. Durst, U. Claussen, G. Ernst. Mass spectrometry meets chip technology, A new proteomic tool in cancer research? Electrophoresis 22, 2898-2902 (2001).
16. Fung, E. T. and C. Enderwick. ProteinChip clinical proteomics, computational challenges and solutions. Biotechniques 32, 1-7 (2002).
17. Ball, G., S. Mian, F. Holding, R. O. Allibone, J. Lowe, S. Ali, G. Li, S. McCardle, I. O. Ellis, C. Creaser, R. C. Rees. An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumors and rapid identification of potential biomarkers. Bioinformatics 18, 395-404 (2002).
18. Petricoin, E. F., A. M. Ardekani, B. A. Hitt, P. J. Levine, V. A. Fusaro, S. M. Steinberg, G. B. Mills, C. Simone, D. A. Fishman, E. C. Kohn, L. A. Liotta. Use of proteomic patterns in serum to identify ovarian cancer. The Lancet 359, 572-577 (2002).